MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-17-0024387
Korten Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹33.11 Cr
▼ 8% YoY
Net loss · FY 2025
₹83.72 Lakh
Net margin -2.5%
EBITDA · FY 2025
₹1.42 Cr
EBITDA margin 4.3%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
₹1.4 Cr
Satisfied ₹50.42 Cr
Company age
36 yrs
Est. 1990
Employees · EPFO
184
Provident fund records
About Korten Pharmaceuticals Private Limited
Data last updated:
Korten Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Neon Laboratories Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 November 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1990PTC058797. Its GSTIN is 27AAACK5781D1ZK (Maharashtra).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Rahul Ashokkumar Jain and Uttamchand Kesharimal Jain.
Its last annual general meeting (AGM) was held on 19 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gala No.40 Damji Shamji Industrial Complex Mahakali Caves Road Andheri East, Mumbai, Maharashtra, India – 400093.
As per the financials filed for FY 2025, the company reported a revenue of ₹33.11 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net loss of ₹83.72 Lakh (net margin -2.5%) and EBITDA of ₹1.42 Cr (EBITDA margin 4.3%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 1% over five years.
The company has about 184 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Korten pharmaceutical. As per MCA filings, the company has open charges of ₹1.4 Cr and satisfied charges of ₹50.42 Cr on record.
Korten Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0024387). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website korten.in.
Company details
CIN U24239MH1990PTC058797
Registration Number 058797
Incorporation Date 05 November 1990
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 19 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Neon Laboratories Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-17-0024387
Key People
Rahul Ashokkumar Jain Director Uttamchand Kesharimal Jain Director Pravin Keshrimal Jain Director Recognitions & Rankings of Korten Pharmaceuticals
Contact details
Korten Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is korten.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGala No.40 Damji Shamji Industrial Complex Mahakali Caves Road Andheri East, Mumbai, Maharashtra, India – 400093
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Korten Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Korten Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Korten Pharmaceuticals operates one associated brand: Korten pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical drugs and healthcare products for clients in India. | korten.in |
Business activity
The main business activity of Korten Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Korten Pharmaceuticals Private Limited, buy the company report.
Financials of Korten Pharmaceuticals Private Limited
FY 2025 filings availableKorten Pharmaceuticals Private Limited reported revenue of ₹33.11 Cr (down 8% YoY) for FY 2025.
Revenue · FY 2025
₹33.11 Cr ▼ 8%
Net loss · FY 2025
₹83.72 Lakh margin -2.5%
EBITDA · FY 2025
₹1.42 Cr margin 4.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 12%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▼ 84%
3 years · compounded
▼ 26%
5 years · compounded
▼ 27%
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 8% fall in the latest year. EBITDA fell 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.42 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹83.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | ||||
| Net Profit Margin | -2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Korten Pharmaceuticals Private Limited, buy the company report.
Board of directors of Korten Pharmaceuticals Private Limited
Korten Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Ashokkumar Jain Also directs: VHB Medi Sciences Limited, Sndev Healthcare Limited, VHB Life Sciences Limited and 2 more | Director | 05 Jan 2013 | 13 Years 9 Months | Current |
| Uttamchand Kesharimal Jain Also directs: Neon Laboratories Limited, Axiommax Oncology Private Limited, VHB Pharmaceuticals Private Limited and 5 more | Director | 05 Jan 2013 | 13 Years 9 Months | Current |
| Pravin Keshrimal Jain Also directs: Neon Laboratories Limited, VHB Pharmaceuticals Private Limited, VHB Medi Sciences Limited and 5 more | Director | 15 Feb 2014 | 12 Years 8 Months | Current |
Peer comparison
Korten Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cureza Healthcare Private Limited | ₹33.53 Cr (FY 2025) | 74.0% | Indore, Madhya Pradesh, India | |||
| Stafford Laboratories Private Limited | ₹33.42 Cr (FY 2024) | 14.0% | Kolkata, West Bengal, India | |||
| Pegasus Farmaco (India) Private Limited | ₹33.13 Cr (FY 2021) | -34.0% | Telangana, India | |||
| Korten Pharmaceuticals Private Limitedthis company | ₹33.11 Cr (FY 2025) | -₹83.72 Lakh | -2.5% | -8.0% | 184 | Mumbai, Maharashtra, India |
| Kim Laboratories Pvt Ltd | ₹33.1 Cr (FY 2025) | 4.0% | Haryana, India | |||
| Health Care Formulations Private Limited | ₹33.06 Cr (FY 2023) | 29.0% | Vadodara, Gujarat, India | |||
| Saar Biotech Private Limited | ₹33.04 Cr (FY 2024) | 20.0% | Chandigarh, India | |||
| Orichem Drugs & Pharmaceuticals Pvt. Ltd. | ₹33.03 Cr (FY 2025) | 21.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Korten Pharmaceuticals Private Limited, buy the company report.
Auditor
Korten Pharmaceuticals Private Limited is audited by GMJ & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GMJ & Co | FY 2024 | 103429W |
Shareholding
The shareholding of Korten Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Korten Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.4 Cr
Satisfied charges
₹50.42 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Feb 1996 | 90153235 | The Hongkong and Shanghai Banking Corporation Limited | ₹50 Lakh | Open | |
| 05 Feb 1996 | 90154521 | The Hongkong and Shanghai Banking Corporation Limited | ₹50 Lakh | Open | |
| 02 Nov 1994 | 90153071 | The Hongkong and Shanghai Banking Corporation Limited | ₹40 Lakh | Open | |
| 04 Jul 2019 | 100278356 | Others | ₹1.85 Cr | Satisfied | |
| 05 Nov 2016 | 100063351 | Others | ₹2 Cr | Satisfied |
To see the full charge records of Korten Pharmaceuticals Private Limited, buy the company report.
Total charge records: 27 View all charges
Legal cases
No court or tribunal cases involving Korten Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Korten Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Korten Pharmaceuticals Private Limited has a workforce of 184 employees on its EPFO records as of Mar 18, 2025, across 1 active EPFO establishment.
Employee count
184
Active EPFO establishments
1
Employee growth
4.55%
GST
Korten Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACK5781D1ZK | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Korten Pharmaceuticals Private Limited, buy the company report.
Recent activity
Korten Pharmaceuticals Private Limited has 9 board changes on record since 2008: 3 appointments and 6 cessations. The latest: Pravin Keshrimal Jain ceased to be Additional Director on 27 Sep 2014.
AGM
Korten Pharmaceuticals Private Limited last Annual general meeting of members was held on 19 Sep 2025 as per latest MCA records.
Filing
Korten Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 28 Feb 1995 via Charge ID 90152463 with Maharashtra State Financial Corporation was fully satisfied on 30 Aug 2022.
Charges
A charge registered on 28 Jun 2002 via Charge ID 90153903 with Janakalyan Sahakari Bank Ltd. was fully satisfied on 24 Jun 2021.
Charges
A charge registered on 22 Sep 2001 via Charge ID 90153842 with Janakalyan Sahakari Bank Ltd. was fully satisfied on 24 Jun 2021.
Charges
A charge registered on 20 Sep 2001 via Charge ID 90154654 with Janakalyan Sahakari Bank Ltd. was fully satisfied on 24 Jun 2021.
Charges
A charge registered on 28 Sep 2001 via Charge ID 90154656 with Sicom Limited was fully satisfied on 23 Mar 2021.
Charges
A charge registered on 14 May 1999 via Charge ID 90154846 with Sicom Limited was fully satisfied on 23 Mar 2021.
Charges
A charge registered on 29 Sep 1998 via Charge ID 90154838 with Sicom Limited was fully satisfied on 23 Mar 2021.
Charges
A charge registered on 11 Mar 2014 via Charge ID 10488613 with Bassein Catholic Co-Operative Bank Limited was fully satisfied on 04 Mar 2021.
Charges
A charge registered on 16 Jan 2014 via Charge ID 10476225 with Bassein Catholic Co-Operative Bank Limited was fully satisfied on 04 Mar 2021.
Charges
A charge registered on 07 May 2010 via Charge ID 10222204 with Others was fully satisfied on 04 Mar 2021.
58 earlier events are in the company report.
Frequently asked questions
Korten Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 November 1990 (36+ years old) and is registered under CIN U24239MH1990PTC058797.
Korten Pharmaceuticals has 3 current directors:
- Rahul Ashokkumar Jain - Director
- Uttamchand Kesharimal Jain - Director
- Pravin Keshrimal Jain - Director
The latest financial statements of Korten Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 19 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Korten Pharmaceuticals is 27AAACK5781D1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Korten Pharmaceuticals is U24239MH1990PTC058797. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Korten Pharmaceuticals was incorporated on 05 November 1990, making it 36+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Korten Pharmaceuticals by revenue are Cureza Healthcare Private Limited, Stafford Laboratories Private Limited, Pegasus Farmaco (India) Private Limited, Kim Laboratories Pvt Ltd, Health Care Formulations Private Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pravin Keshrimal Jain ceased to be Additional Director on 27 Sep 2014. Neelam Sandeep Mhatre ceased to be Director on 11 Jul 2014. Pravin Keshrimal Jain was appointed as Director on 15 Feb 2014. Korten Pharmaceuticals has 9 board changes on record in total.
Yes, Korten Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-17-0024387).
Korten Pharmaceuticals can be reached through the website korten.in. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Korten Pharmaceuticals is at Gala No.40 Damji Shamji Industrial Complex Mahakali Caves Road Andheri East, Mumbai, Maharashtra, India – 400093.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages